Paper
Document
Download
Flag content
0

Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial

0
TipTip
Save
Document
Download
Flag content